⌕
Moderna · MRNA · Nasdaq
Tenet 33 · Weak
Compare
$206.80−3.93%At closeTenet 33 · Weak
$206.80−8.47 (−3.93%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$209.40+2.60 (+1.26%)
After hours: Nov 17, 2026, 7:54 PM ET

Moderna (MRNA) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Business engineChoppy: revenue is 90% below its peak, net margin −145.2%. Worth your attention in FY25: Returns vs FCF (n/m). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼39.9%
1,944.0
FY21→FY25CAGR −43.0%/yr
Net income ($M)▲20.8%
−2,822.0
one-off year: see footnoteCAGR —
Free cash flow ($M)▲49.1%
−2,065.0
FY21→FY25CAGR —
Diluted EPS▲21.8%
−7.26
buyback-liftedCAGR —
What the receipts whisper · what a headline number hides
Share count
−9.7%

431.0mn → 389.0mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$192.0M

−81.7% YoY in FY25 · 9.9% of revenue.

Returns vs FCF
n/m

$0.0B returned vs $−2.1B of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)1944.0Revenue−868.0COGS1076.0Gross profit−3132.0R&D−1018.0SG&A−3074.0Op income252.0Tax & other−2822.0Net income

-145¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
806040200%sector median net margin ~3%FY21FY25

Net margin -145.2% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
2,525.01,944.03,236.06,848.019,263.018,471.0▼39.9%−43.0%
Cost of revenue
1,818.0868.01,464.04,693.05,416.02,617.0▼40.7%−24.1%
Gross profit
707.01,076.01,772.02,155.013,847.0—A▼39.3%−57.3%
Research & development
2,658.03,132.04,543.04,845.03,295.01,991.0▼31.1%+12.0%
Selling, general & admin
979.01,018.01,174.01,549.01,132.0567.0▼13.3%+15.8%
Total operating expenses
3,637.04,150.05,717.06,394.04,427.02,558.0▼27.4%+12.9%
Operating incomefeeds ROC rank
−2,930.0−3,074.0−3,945.0−4,239.09,420.013,296.0▲22.1%—
Other income, net
201.0306.0338.0297.0155.0−11.0——
Pretax income
−2,729.0−2,768.0−3,607.0−3,942.09,575.013,285.0▲23.3%—
Income tax
60.054.0−46.0772.01,213.01,083.0—−52.7%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−2,789.0−2,822.0−3,561.0−4,714.08,362.012,202.0▲20.8%—
Per share
Diluted EPSbuyback-sensitive
−7.09−7.26−9.28−12.3320.1228.29▲21.8%—
Diluted shares (mn)
430.00389.00384.00382.00416.00431.00▲1.3%−2.5%
Margins
Gross margin11th pct in Healthcare
28.0%55.3%54.8%31.5%71.9%—A▲0.6pp−16.5pp
Operating margin
−116.0%−158.1%−121.9%−61.9%48.9%72.0%▼36.2pp−230.1pp
Net margin9th pct in Healthcare
−110.5%−145.2%−110.0%−68.8%43.4%66.1%▼35.1pp−211.2pp
† TTM = trailing four quarters through 2026-09-30.FY22 effective tax rate was 13% vs a 1% norm for this window, likely a one-time item; see the filing.FY23 effective tax rate was −20% vs a 1% norm for this window, likely a one-time item; see the filing.A Withheld: this year's gross margin is not on the same cost basis as the earlier years.
FY16 – FY20 · 5 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-20 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Moderna's revenue last fiscal year?

Moderna reported revenue of $1,944.0M in fiscal 2025, down 39.9% from fiscal 2024.

What was Moderna's net income?

Moderna reported net income of −$2,822.0M in fiscal 2025, a net margin of −145.2%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.